Edition:
India

Profile: Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

84.50PLN
18 Apr 2019
Change (% chg)

-0.30zł (-0.35%)
Prev Close
84.80zł
Open
85.00zł
Day's High
85.00zł
Day's Low
81.20zł
Volume
2,445
Avg. Vol
10,610
52-wk High
124.00zł
52-wk Low
66.00zł

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The Company specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. It focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. It operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.

Company Address

Mabion SA

ul. gen. Mariana Langiewicza 60
KONSTANTYNOW LODZKI     95-050
P: +4842.2077890
F: +4842.2032703

Company Web Links